MARX Biotech Co., Ltd.(TW:7731)
NT$4.26-0.09 (-2.07%)
TW:7731
MARX Biotech Co., Ltd. financials statements
NT$4.26
At close:-0.09 (-2.07%)
MARX Biotech Co., Ltd. (7731) Income Statement
MARX Biotech Co., Ltd. Income Statement
Last quarter (Q2 2026), MARX Biotech Co., Ltd.'s total revenue was NT$257.81M, an increase of 66.91% from the same quarter last year. In Q2, MARX Biotech Co., Ltd.'s net income was NT$-48.94M. See MARX Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 635.85M | NT$ 618.23M | NT$ 289.93M | NT$ 110.64M | NT$ 97.61M | |
| NT$ 394.59M | NT$ 430.07M | NT$ 214.59M | NT$ 84.21M | NT$ 74.79M | |
| NT$ 534.05M | NT$ 507.46M | NT$ 228.93M | NT$ 83.31M | NT$ 59.74M | |
| Depreciation and Amortization | NT$ 19.52M | NT$ 17.98M | NT$ 4.59M | NT$ 1.95M | NT$ 1.32M |
| NT$ 91.00M | NT$ -77.25M | NT$ -10.52M | NT$ 6.97M | NT$ 19.01M | |
| NT$ -139.46M | NT$ -77.39M | NT$ -14.34M | NT$ 898.00K | NT$ 15.05M | |
| NT$ 197.24M | NT$ -20.04M | NT$ 1.40M | NT$ 4.01M | NT$ 2.59M | |
| NT$ 57.78M | NT$ -97.43M | NT$ -15.49M | NT$ 4.91M | NT$ 17.64M | |
| NT$ 42.92M | NT$ -96.83M | NT$ -12.92M | NT$ 2.83M | NT$ 13.78M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.09 | NT$ -0.19 | NT$ -0.03 | NT$ 0.02 | NT$ 0.10 |
| Diluted EPS | NT$ 0.08 | NT$ -0.19 | NT$ -0.03 | NT$ 0.02 | NT$ 0.10 |
| Weighted Average Shares Outstanding | 475.27M | 509.61M | 498.06M | 172.93M | 137.78M |
| Weighted Average Shares Outstanding (Diluted) | 505.98M | 509.61M | 498.06M | 174.22M | 137.78M |
Currency in TWD
